tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market
Advertisement

Fulcrum Therapeutics (FULC) Similar Stocks

Compare
504 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Fulcrum Therapeutics
$10.94
$635.35M
181.96%
7 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$86.18
$575.91M
291.55%
12 Buy
0 Hold
0 Sell
Strong Buy
ADC Therapeutics
$4.30
$532.67M
85.34%
3 Buy
0 Hold
0 Sell
Strong Buy
Opthea Limited Sponsored ADR
$0.11
$477.76M
-3.01
-97.09%
0 Buy
0 Hold
0 Sell
Hold
Monte Rosa Therapeutics
$16.17
$1.05B
52.95
58.22%
4 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$84.12
$1.22B
457.82%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FULC
Fulcrum Therapeutics
10.94
7.06
181.96%
MNPR
Monopar Therapeutics Inc
86.18
64.17
291.55%
ADCT
ADC Therapeutics
4.30
1.98
85.34%
OPT
Opthea Limited Sponsored ADR
0.11
-3.60
-97.04%
GLUE
Monte Rosa Therapeutics
16.17
5.95
58.22%
INBX
Inhibrx Biosciences Inc
84.12
69.04
457.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis